Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)
All News about Corcept Therapeutics Incorporated - Common Stock
Corcept Therapeutics Initiates CATALYST Clinical Trial
March 28, 2023
Via GlobeNewswire
Corcept Therapeutics Provides Miricorilant Clinical Development Update
December 08, 2022
Via GlobeNewswire